Movicol and Mirabegron drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Movicol (polyethylene glycol 3350) and Mirabegron (mirabegron). Common drug interactions include lower respiratory tract infection among females and thrombocytopenia among males.
The phase IV clinical study analyzes what interactions people have when they take Movicol and Mirabegron. It is created by eHealthMe based on reports of 106 people who take the same drugs from the FDA, and is updated regularly.
What is Movicol?
Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.
What is Mirabegron?
Mirabegron has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 5,414 Mirabegron users. Check the latest studies of Mirabegron.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
106 people who take Movicol and Mirabegron together, and have interactions are studied.
What are the common drug interactions of Movicol and Mirabegron, by gender? *
What are the common drug interactions of Movicol and Mirabegron, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Movicol and Mirabegron?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Movicol (14,249 reports)
- Mirabegron (5,414 reports)
Browse all drug interactions of Movicol and Mirabegron:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Movicol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Mirabegron:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Movicol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mirabegron and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on polyethylene glycol 3350 and mirabegron (the active ingredients of Movicol and Mirabegron, respectively), and Movicol and Mirabegron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Thorazine vs. Clonidine Hydrochloride, side effect and effectiveness comparison - 10 seconds ago
- Could Cortisporin cause Dizziness? - 16 seconds ago
- Vitamin D3 and Insomnia for Women aged 40-49 - 17 seconds ago
- Vitamin D3 and Can'T Sleep for Women aged 40-49 - 17 seconds ago
- Vitamin D3 and Agrypnia for Women aged 40-49 - 17 seconds ago
- Vitamin D3 and Insomnia Concerns for Women aged 40-49 - 17 seconds ago
- Vitamin D3 and Difficulty Falling Asleep for Women aged 40-49 - 18 seconds ago
- Vitamin D3 and Sleeplessness for Women aged 40-49 - 18 seconds ago
- Vitamin D3 and Sleeping for Women aged 40-49 - 18 seconds ago
- Vitamin D3 and Cannot Sleep for Women aged 40-49 - 19 seconds ago